VAPA and small cell lung carcinoma: Two independent siRNAs targeting the back-spliced junction site of circVAPA resulted in the effective silence of circVAPA in SCLC cells, whereas no significant changes on VAPA mRNA (Fig. 2A and Fig. S2A).